In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods and more. The goal: To allow regulatory professionals to better anticipate and prepare for upcoming events and catalysts.
What we expect to be talking about in July:
July shapes up to be a very slow month: Yes, even regulators slow down over the summer, and July appears to be one of the slowest months for planned regulatory actions in quite some time.
Fill out the form to read the full article.
